Clinical Trial Detail

NCT ID NCT03469011
Title A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

thyroid gland papillary carcinoma

Therapies

Imatinib

Age Groups: senior adult

No variant requirements are available.